AmSurg Corp
AmSurg Corp Fundamental Analysis
AmSurg Corp (AMSG) shows weak financial fundamentals with a PE ratio of 19.98, profit margin of 6.35%, and ROE of 8.20%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 55.2/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze AMSG's fundamental strength across five key dimensions:
Efficiency Score
WeakAMSG struggles to generate sufficient returns from assets.
Valuation Score
ExcellentAMSG trades at attractive valuation levels.
Growth Score
WeakAMSG faces weak or negative growth trends.
Financial Health Score
ModerateAMSG shows balanced financial health with some risks.
Profitability Score
WeakAMSG struggles to sustain strong margins.
Key Financial Metrics
Is AMSG Expensive or Cheap?
P/E Ratio
AMSG trades at 19.98 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, AMSG's PEG of 0.20 indicates potential undervaluation.
Price to Book
The market values AmSurg Corp at 1.42 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -4.60 times EBITDA. This is generally considered low.
How Well Does AMSG Make Money?
Net Profit Margin
For every $100 in sales, AmSurg Corp keeps $6.35 as profit after all expenses.
Operating Margin
Core operations generate 24.06 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $8.20 in profit for every $100 of shareholder equity.
ROA
AmSurg Corp generates $2.49 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $9.94 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
19.98
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.20
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.42
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.06
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.37
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.10
vs 25 benchmark
How AMSG Stacks Against Its Sector Peers
| Metric | AMSG Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 19.98 | 28.36 | Better (Cheaper) |
| ROE | 8.20% | 751.00% | Weak |
| Net Margin | 6.35% | -46319.00% (disorted) | Weak |
| Debt/Equity | 1.06 | 0.34 | Weak (High Leverage) |
| Current Ratio | 1.37 | 4.13 | Neutral |
| ROA | 2.49% | -17844.00% (disorted) | Weak |
AMSG outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews AmSurg Corp's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation